144 related articles for article (PubMed ID: 19099253)
1. Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma.
Dissanayake SK; Weeraratna AT
Methods Mol Biol; 2008; 468():157-72. PubMed ID: 19099253
[TBL] [Abstract][Full Text] [Related]
2. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
4. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
5. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS; Apostolatos AH; Ostrov DA; Acevedo-Duncan M
Int J Oncol; 2017 Nov; 51(5):1370-1382. PubMed ID: 29048609
[TBL] [Abstract][Full Text] [Related]
6. Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts.
Martineau X; Abed É; Martel-Pelletier J; Pelletier JP; Lajeunesse D
PLoS One; 2017; 12(8):e0180711. PubMed ID: 28777797
[TBL] [Abstract][Full Text] [Related]
7. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
Dissanayake SK; Olkhanud PB; O'Connell MP; Carter A; French AD; Camilli TC; Emeche CD; Hewitt KJ; Rosenthal DT; Leotlela PD; Wade MS; Yang SW; Brant L; Nickoloff BJ; Messina JL; Biragyn A; Hoek KS; Taub DD; Longo DL; Sondak VK; Hewitt SM; Weeraratna AT
Cancer Res; 2008 Dec; 68(24):10205-14. PubMed ID: 19074888
[TBL] [Abstract][Full Text] [Related]
8. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
9. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
10. cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells.
Bazhin AV; Tambor V; Dikov B; Philippov PP; Schadendorf D; Eichmüller SB
Cell Mol Life Sci; 2010 Mar; 67(5):817-28. PubMed ID: 19946729
[TBL] [Abstract][Full Text] [Related]
11. Engagement of protein kinase C-theta in interferon signaling in T-cells.
Srivastava KK; Batra S; Sassano A; Li Y; Majchrzak B; Kiyokawa H; Altman A; Fish EN; Platanias LC
J Biol Chem; 2004 Jul; 279(29):29911-20. PubMed ID: 15150272
[TBL] [Abstract][Full Text] [Related]
12. p300/β-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC).
Rieger ME; Zhou B; Solomon N; Sunohara M; Li C; Nguyen C; Liu Y; Pan JH; Minoo P; Crandall ED; Brody SL; Kahn M; Borok Z
J Biol Chem; 2016 Mar; 291(12):6569-82. PubMed ID: 26833564
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C in Wnt signaling: implications in cancer initiation and progression.
Luna-Ulloa LB; Hernández-Maqueda JG; Castañeda-Patlán MC; Robles-Flores M
IUBMB Life; 2011 Oct; 63(10):915-21. PubMed ID: 21905203
[TBL] [Abstract][Full Text] [Related]
14. PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.
Desai S; Pillai P; Win-Piazza H; Acevedo-Duncan M
Biochim Biophys Acta; 2011 Jun; 1813(6):1190-7. PubMed ID: 21419810
[TBL] [Abstract][Full Text] [Related]
15. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
16. RACK1 mediates activation of JNK by protein kinase C [corrected].
López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II type 1A receptor phosphorylation, phospholipase D, and extracellular calcium in isoform-specific protein kinase C membrane translocation responses.
Policha A; Daneshtalab N; Chen L; Dale LB; Altier C; Khosravani H; Thomas WG; Zamponi GW; Ferguson SS
J Biol Chem; 2006 Sep; 281(36):26340-9. PubMed ID: 16831865
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon).
Brändlin I; Eiseler T; Salowsky R; Johannes FJ
J Biol Chem; 2002 Nov; 277(47):45451-7. PubMed ID: 12223477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
